"Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
| Descriptor ID |
D014157
|
| MeSH Number(s) |
D12.776.930
|
| Concept/Terms |
Transcription Factors- Transcription Factors
- Factors, Transcription
- Transcription Factor
- Factor, Transcription
|
Below are MeSH descriptors whose meaning is more general than "Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Transcription Factors".
This graph shows the total number of publications written about "Transcription Factors" by people in this website by year, and whether "Transcription Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 14 | 10 | 24 |
| 1997 | 28 | 14 | 42 |
| 1998 | 25 | 9 | 34 |
| 1999 | 35 | 11 | 46 |
| 2000 | 38 | 14 | 52 |
| 2001 | 45 | 12 | 57 |
| 2002 | 44 | 27 | 71 |
| 2003 | 48 | 32 | 80 |
| 2004 | 58 | 23 | 81 |
| 2005 | 46 | 36 | 82 |
| 2006 | 30 | 21 | 51 |
| 2007 | 31 | 25 | 56 |
| 2008 | 29 | 17 | 46 |
| 2009 | 28 | 21 | 49 |
| 2010 | 31 | 18 | 49 |
| 2011 | 24 | 19 | 43 |
| 2012 | 27 | 26 | 53 |
| 2013 | 30 | 32 | 62 |
| 2014 | 27 | 39 | 66 |
| 2015 | 35 | 25 | 60 |
| 2016 | 30 | 28 | 58 |
| 2017 | 31 | 32 | 63 |
| 2018 | 28 | 17 | 45 |
| 2019 | 20 | 30 | 50 |
| 2020 | 31 | 32 | 63 |
| 2021 | 26 | 22 | 48 |
| 2022 | 8 | 30 | 38 |
| 2023 | 18 | 35 | 53 |
| 2024 | 20 | 20 | 40 |
| 2025 | 21 | 15 | 36 |
| 2026 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcription Factors" by people in Profiles.
-
Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells. Mol Cancer Ther. 2026 May 04; 25(5):844-859.
-
Important role in transcription start site selection for the RNA polymerase II-TFIIE-TFIIH interface in Saccharomyces cerevisiae. Genetics. 2026 04 04; 232(4).
-
Family single-cell atlases reveal pig pregnancy and fetal growth restriction critical cell types. Science. 2026 Mar 26; 391(6792):eadu7265.
-
Dominant clones leverage developmental epigenomic states to drive ependymoma. Nature. 2026 04; 652(8111):1027-1037.
-
Frequent synaptophysin expression in SMARCA4-deficient undifferentiated carcinoma of the oesophagus: a diagnostic pitfall with therapeutic implications. J Clin Pathol. 2026 Mar 19; 79(4):229-237.
-
TEAD-independent mechanisms of YAP function in cardiomyocyte cell cycle reentry. Life Sci Alliance. 2026 Apr; 9(4).
-
Characterizing the interactions between murine cytomegalovirus M72 and the carbon catabolite repression 4-negative on TATA-less (CCR4-NOT) complex. Virology. 2026 Mar; 616:110791.
-
KRAS-ERK signaling drives metastasis in colorectal cancer via phosphorylation-dependent activation of the ZBTB20-TGFBR2 axis. J Exp Clin Cancer Res. 2026 Jan 02; 45(1):29.
-
Therapeutic p63 isoform switching rescues epidermal defects in AEC syndrome. Mol Ther. 2026 Apr 01; 34(4):2324-2342.
-
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML. Leukemia. 2026 Feb; 40(2):304-313.